Skip to main content

$0.076 -0.001 (-1.30%)

High

$0.08

Low

$0.07

Trades

8

Turnover

$9,058

Volume

120,981
30 June 2023 at 2:59pm
Register to track ATX and receive email alerts.
Subject
ATX Ann: Application for quotation of securities - ATX

ATX Ann: Annual General Meeting to be held Thursday 25 August 2022

ATX Ann: Registered Office and Principal Place of Business

ATX Ann: Notification of Expiry of Unlisted Options

ATX Ann: Application for quotation of securities - ATX

ATX Ann: AMP945 Shows Efficacy in Model of Lung Fibrosis

ATX Ann: App 4G - Key to Corporate Governance Disclosures

ATX Ann: 2022 Corporate Governance Statement

ATX Ann: Preliminary Final Report and Annual Report YE 31 March 2022

ATX Ann: Amplia Receives Second Ethics Clearance for Phase 2 Trial

ATX Ann: Amplia Presentation to 16th Bioshares Biotech Summit

ATX Ann: AMP945 Pre-IND Meeting Outcome

ATX Ann: Quarterly Activities and Cashflow Reports - March 2022 Qtr

ATX Ann: Ethics Clearance Phase 2 Trial - Pancreatic Cancer Patients

ATX Ann: Notification of cessation of securities - ATX

ATX Ann: AMP945 Improves Survival in Human Pancreatic Cancer Model

ATX Ann: ATX Abstract accepted for presentation at Cancer Conference

ATX Ann: Sale of Unmarketable Parcels of Shares

ATX Ann: Change of Director's Interest Notice - Jane Bell

ATX Ann: Amplia Investor Presentation - February 2022

ATX Ann: Quarterly Activities and Cashflow Reports - Dec 2021 Qtr

ATX Ann: Notification regarding unquoted securities - ATX

ATX Ann: Amplia Completes Manufacture of AMP945 for Planned Trials

ATX Ann: Change in substantial holding

ATX Ann: Application for quotation of securities - ATX

ATX Ann: Application for quotation of securities - ATX

ATX Ann: Change in substantial holding

ATX Ann: App 3Y - Change of Director's Interest - Mrs Jane Bell

ATX Ann: App 3Y - Change of Director's Interest - Dr. Chris Burns

ATX Ann: App 3Y - Change of Director's Interest - Dr. Robert Peach

ATX Ann: App 3Y - Change of Director's Interest - Dr. John Lambert

ATX Ann: App 3Y - Change of Directors Interest Notice - Dr. W. Tong

ATX Ann: Proposed issue of securities - ATX

ATX Ann: Update - Application for quotation of securities - ATX

ATX Ann: Results of Extraordinary General Meeting

ATX Ann: Amplia Provides Updated Investor Presentation

ATX Ann: Change in substantial holding

ATX Ann: Update - Application for quotation of securities - ATX

ATX Ann: Update - Proposed issue of securities - ATX

ATX Ann: Entitlement Offer Completed

ATX Ann: Amplia Awarded $2.1M R&D Cash Flow Loan

ATX Ann: App 4D and Financial Report Half Year ended 30 Sep 2021

ATX Ann: Notice of Extraordinary General Meeting - 17 Dec 2021

ATX Ann: Summary Results - Successful Phase 1 Clinical Trial AMP945

ATX Ann: Inhibition of FAK by AMP945 in Phase 1 Clinical Trial

ATX Ann: Becoming a substantial holder

ATX Ann: Application for quotation of securities - ATX

ATX Ann: Change in substantial holding

ATX Ann: Application for quotation of securities - ATX

ATX Ann: Section 708A Cleansing Notice - Share Placement

Register to track ATX and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX